http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008542211-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 |
filingDate | 2006-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2008-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2008542211-A |
titleOfInvention | Use of polymer blends for the manufacture of coated pharmaceutical formulations and polymer blend coated pharmaceutical formulations |
abstract | The present invention relates to the use of a mixture of 2 to 60% by weight of one or more polymers (I) and 40 to 98% by weight of one or more polymers (II), wherein the polymer (I) is acrylic acid or methacrylic having C 1 -C 4 alkyl esters 40-95 wt% 90 to 100% by weight and the radical polymerization of and other vinyl polymerizable monomers 0 to 10% by weight of the anionic groups of the acid (meth) acrylate monomer units (Meth) acrylate copolymer containing 5 to 60% by mass, polymer (II) is a vinyl polymer different from polymer (I), or less than 12% by mass having neutral monomer units and ionic groups of 88 to 100% In order to produce coated pharmaceutical formulations, polymers (I) and (I A polymer comprising an active agent core and a polymer coating made from a mixture of (1), wherein the polymer (I) has a glass transition temperature of 70 ° C. or less, obtains active agent release properties and initiates this active agent release at the same pH It relates to a use characterized in that it is delayed in a coated pharmaceutical preparation having a coating produced other than (I). The invention further relates to a pharmaceutical formulation having a selected polymer (I). |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012520831-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021515778-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018020968-A |
priorityDate | 2005-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1190.